We are happy to announce that ETAT's application for Scopus has been approved. Within one month, ETAT journal will be listed in the Scopus Title list.
This is a great embodiment of ETAT's rapid development in just two years since launched, and an important step in being acknowledged as a valuable academic publication.
We appreciate all Editors, board members, authors, reviewers, and everyone who has contributed to this.
Annual Development Report 2025 of Exploration of Targeted Anti-tumor Therapy
Annual Development Report 2024 of Exploration of Targeted Anti-tumor Therapy
ETAT Recent Exposure at MMCD 2025
Prof. Pier Paolo Piccaluga Promotes ETAT at CMID 2025